• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    22.67 Up 0.80(3.66%) Mar 27, 4:00PM EDT
    |After Hours : 22.53 Down 0.14 (0.62%) Mar 27, 5:47PM EDT
    Add to Portfolio
    Prev Close:21.87
    Open:21.95
    Bid:21.87 x 200
    Ask:35.00 x 1000
    1y Target Est:24.50
    Beta:1.67
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:21.91 - 22.85
    52wk Range:9.85 - 25.54
    Volume:1,001,513
    Avg Vol (3m):1,426,410
    Market Cap:1.35B
    P/E (ttm):11.05
    EPS (ttm):2.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPOUp 3.66%1.35B
    MRKUp 0.26%163.91B
    PFEUp 1.08%211.63B
    TEVADown 0.70%52.80B

    Key Statistics

    Forward P/E (1 yr):26.99
    P/S (ttm):3.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.35
    Quarterly EPS Est (Mar-15) :0.01
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):2.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback